source Post navigation Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial – CNBC Almost 40% of older adults with polypharmacy given inappropriate prescription when starting treatment for type 2 … – The Pharmaceutical Journal